Drug Stocks Favored by Funds

Description:

According to Robert Holmes, "Drug stocks such as Johnson & Johnson (JNJ) and Gilead Sciences (GILD) have been beaten up in the year since the health-care reform bill was passed. That may soon change, as fund managers are pouncing on shares of undervalued companies." Here are the health-care equity picks of two fund managers and an analyst. Read more here.

>>Also: 10 Buy-Rated Stocks Under $5

>>Also: 4 Small Stocks With Buyout Rumors

Most Viewed Portfolios

View All

Articles

5 Big Stocks to Trade for Gains as QE3 Ends

10.30.14 | 11:03 AM

BALTIMORE (Stockpickr) -- The Fed is shutting the tap this week, ending the QE3 bond-.buying program that's arguably been one of the biggest struct...

5 Stocks Spiking on Unusual Volume

10.30.14 | 07:00 AM

DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter